Mizolastine

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Indication
This section has been translated automatically.

Symptomatic treatment of seasonal and perennial allergic rhinoconjunctivitis and urticaria.

Pregnancy/nursing period
This section has been translated automatically.

Contraindicated in the 1st trimester; mizolastine should not be prescribed during pregnancy and lactation (insufficient data available).

Dosage and method of use
This section has been translated automatically.

Adults, children > 12 years.: once/day 10 mg p.o.

Undesirable effects
This section has been translated automatically.

Gastrointestinal symptoms (diarrhoea, abdominal pain, dyspepsia, dry mouth, nausea), fatigue and tiredness, headaches, dizziness.

Interactions
This section has been translated automatically.

Ketoconazole & Erythromycin: Moderate increase of the plasma concentration of mizolastine. Strong inhibitors or substrates of liver oxidation (cytochrome P 450 3A4), e.g. cimetidine, ciclosporin, nifedipine: slowed biotransformation and thus prolonged effect of mizolastine are possible.

Preparations
This section has been translated automatically.

Mizollen, Zolim

Note(s)
This section has been translated automatically.

Diabetics or patients with electrolyte disturbances/cardiac arrhythmia should be regularly checked during therapy.

Literature
This section has been translated automatically.

  1. Borchard U (2003) New H1 antihistamines in comparison. Allergology 1: 23-32

Outgoing links (1)

Antihistamines;

Authors

Last updated on: 29.10.2020